A phase 2/phase 3 clinical trial investigating the efficacy of using circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy in…
Browsing: Liquid Biopsy
At the Gastrointestinal Cancers Symposium in San Francisco, two separate studies presented mixed results regarding the use of liquid biopsy…
The FDA has granted breakthrough device designation to Amadix’s PreveCol, a blood test designed for the early detection of colorectal…
The “ColoSense” multitarget stool RNA test has demonstrated superior sensitivity and specificity for detecting colorectal cancer and advanced adenomas compared…
A recent study conducted by the Regenstrief Institute and led by Research Scientist Thomas F. Imperiale, M.D., suggests that a…
This research, published in Cell Reports Medicine, explores the potential of circulating cell-free RNA (cfRNA) in blood plasma as a…
Universal DX (UDX) and Quest Diagnostics have entered into a commercial agreement to advance colorectal cancer screening in the US…
Lucid Diagnostics, a medical diagnostics company specializing in cancer prevention, has announced the launch of the next generation of its…
Mainz Biomed, a German cancer diagnostic firm, has partnered with Liquid Biosciences to use their artificial intelligence platform, Emerge, for…
Exact Sciences Corporation announced its third-quarter 2023 results. Here’s a summary: